SharpyRetatrutide Price 2026: Why There Is No Real Price Yet
Retatrutide has no real price yet. As of October 30, 2026, Eli Lilly has not announced a price, the drug is not approved anywhere, and Lilly plans to ask the FDA for approval in the first quarter of 2027, so a US launch is unlikely before late 2027. Any "retatrutide price per month" you see online is for unapproved vials that are illegal to sell for human use. The best clue to a future price is what Lilly charges for Zepbound today: $299 to $449 a month self-pay on LillyDirect. While you wait, Sharpy helps you protect muscle on an approved GLP-1 with one protein target and one 20-minute workout a day.
How much does retatrutide cost? Right now, it has no real price. Eli Lilly has not announced one, and no regulator anywhere has approved the drug. Lilly plans to ask the FDA for approval in the first quarter of 2027. Until then, every "retatrutide price" you see online is for vials that are illegal to sell for human use.
People are searching this more than ever. Lilly's head-to-head trial against Ozempic made headlines on October 28, 2026, and "retatrutide peptide price" showed up as a brand-new search this week. Here is what we actually know, what the clues say about a future price, and what you can do today.
Is there an official retatrutide price?
No. As of October 30, 2026, Lilly has not published a list price, a LillyDirect price or a savings card for retatrutide. Lilly's own July 23, 2026 release calls it "an investigational molecule that cannot be legally sold or marketed for human use."
Drugmakers usually set the price right before or right after FDA approval. For Zepbound, Lilly announced the price the day the FDA approved it in November 2023. Expect the same pattern here.
When will retatrutide have a price? The timeline
| Step | Status |
|---|---|
| TRIUMPH-1 obesity trial (no diabetes) | Done: 28.3% average weight loss on 12 mg at 80 weeks |
| TRIUMPH-2 (obesity plus type 2 diabetes) | Done: 20.8% on 12 mg vs 4.0% placebo at 80 weeks |
| TRIUMPH-3 (severe obesity plus heart disease) | Done: 22.6% on 12 mg vs 3.2% placebo at 80 weeks |
| TRANSCEND-T2D-2 vs Ozempic | Topline Oct 28, 2026: 20.9% vs 9.4% weight loss |
| FDA submission (BLA) | Planned for Q1 2027 |
| FDA decision | Not before late 2027 under a standard review; a faster review is possible but not announced |
| Official US price | Expected around approval |
Lilly says it is still finishing the manufacturing data package the FDA requires before it can file. Our retatrutide guide covers each trial, and the retatrutide vs Ozempic guide breaks down the newest results.
Retatrutide price clues: what Lilly charges today
The best way to guess the future is to look at Lilly's current weight-loss drugs. These are real, published prices.
| Lilly drug | Price | Where |
|---|---|---|
| Zepbound list price | About $1,086 a month | Cited in the White House fact sheet, Nov 6, 2025 |
| Zepbound 2.5 mg, vial or KwikPen | $299 a month | LillyDirect self-pay, Oct 29, 2026 |
| Zepbound 5 mg | $399 a month | LillyDirect self-pay |
| Zepbound 7.5 mg to 15 mg | $449 a month (refill within 45 days) | LillyDirect self-pay |
| Foundayo pill, by dose | $149 to $299 a month | LillyDirect self-pay |
| Zepbound with commercial insurance | As low as $25 a month | Zepbound savings card, if eligible |
Two facts may shape retatrutide's price:
- A pricing promise for new drugs. In the November 6, 2025 deal announced by the White House, Lilly and Novo Nordisk agreed to "guarantee MFN prices on all new medicines that they bring to market." MFN means most-favored-nation: a US price no higher than what similar wealthy countries pay. The fact sheet does not name a price for any future drug.
- Cash-pay is now normal. Lilly sells Zepbound and Foundayo straight to patients at fixed monthly prices. A retatrutide self-pay option on LillyDirect would fit that pattern, but Lilly has not said so.
Some websites publish "predicted" retatrutide prices of $800 to $1,200 a month. Those are forecasts by third parties, not Lilly numbers. We do not repeat them as facts.
Why online "retatrutide price per month" listings are not real prices
Search for retatrutide price per month, per dose or per vial, and you will find sellers quoting cheap numbers. Those are not prices for the real medicine. They are for products labeled "research use only" or "not for human consumption."
- They are illegal to sell for people to inject. The FDA has sent warning letters to retatrutide sellers, and Lilly sued six of them in August 2026.
- You cannot know what is inside. A CBS News test of a vial bought at a Brooklyn bodega for $90 found no peptide at all, plus bacteria. Our is retatrutide legal guide covers these tests and warnings.
- A low price is not a bargain if the dose is wrong. Unregulated vials have no checked strength, sterility or expiration date.
This is true in every country. The "retatrutide price" in the UK, India, South Africa, the Philippines or the UAE is also a price for an unapproved product, because no regulator in any of those places has approved it.
Retatrutide price vs tirzepatide and Ozempic
You can compare real prices today only for approved drugs. Here is where the market stands.
| Drug | Approved? | Lowest self-pay price we checked |
|---|---|---|
| Retatrutide | No | No legal price |
| Zepbound (tirzepatide) | Yes | $299 a month, LillyDirect |
| Wegovy pen (semaglutide) | Yes | $349 a month, NovoCare |
| Wegovy pill (semaglutide) | Yes | $149 a month for 1.5 mg, NovoCare |
| Foundayo (orforglipron) | Yes | $149 a month, LillyDirect |
In trials, retatrutide caused more weight loss than any approved drug so far. But approved drugs already deliver real results now, at known prices, with known safety records. See our LillyDirect Zepbound guide and TrumpRx GLP-1 prices for the current options.
What bigger weight loss means for your muscle
Losing 20% or more of your body weight is a lot. Some of that loss can come from muscle, not just fat. That is true on retatrutide, and it is true on Zepbound or Wegovy today.
You do not have to wait for a new drug to start protecting muscle. Sharpy gives you one daily protein target, one 20-minute strength workout and one Shape Score that shows whether the weight you lose is mostly fat. Those habits carry over to any medicine you take later.
Can you get retatrutide now without paying?
Only in a clinical trial. Lilly runs many retatrutide studies, and study drugs are given at no cost. Trials have strict rules on who can join, and you may get a placebo. Our retatrutide clinical trials guide explains how to search ClinicalTrials.gov.
If you are thinking about switching from your current drug once retatrutide arrives, talk to your prescriber first. Do not stop or change a dose on your own.
The bottom line
There is no retatrutide price today, and there will not be one until Lilly is close to FDA approval, likely not before late 2027 unless the review is sped up. Lilly's current self-pay prices ($299 to $449 a month for Zepbound) and its promise of most-favored-nation pricing on new drugs are the best clues. Online "price per month" listings are for unapproved vials, so skip them. In the meantime, an approved GLP-1 plus enough protein and strength training is the proven path. Sharpy keeps that simple with one protein target, one 20-minute workout and one Shape Score a day.
Sources
- Lilly's triple agonist retatrutide successful in two additional Phase 3 obesity trials, Eli Lilly via PR Newswire, July 23, 2026
- Lilly's retatrutide head-to-head trial vs Ozempic, Eli Lilly via PR Newswire, October 28, 2026
- Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients, The White House, November 6, 2025
- LillyDirect Zepbound self-pay pricing
- NovoCare Wegovy self-pay pricing
Questions people ask
How much does retatrutide cost?
There is no official cost. Eli Lilly has not set a price because retatrutide is still an investigational drug. Lilly plans to submit it to the FDA in the first quarter of 2027. A price is normally announced around the time of approval.
What is the retatrutide price per month?
No legal monthly price exists yet. The per-month and per-vial prices on websites, Reddit and social media are for unapproved products sold as "research peptides." Lilly says retatrutide cannot be legally sold or marketed for human use, and tests of such vials have found the wrong drug, no drug or bacteria.
When will retatrutide be available, and at what price?
Lilly plans to file with the FDA in Q1 2027. A standard FDA review takes about 10 months to a year after filing, so late 2027 or 2028 is a realistic window if all goes well, unless the FDA grants a faster review. Nothing is guaranteed. Expect Lilly to announce the price close to launch.
Will retatrutide be more expensive than Zepbound?
No one knows yet. New drugs that work better often launch at a higher list price. But under its November 2025 agreement with the White House, Lilly agreed to guarantee most-favored-nation prices on all new medicines it brings to market, which could hold the US price closer to what other rich countries pay. Any number you see today is a guess.
Will insurance cover retatrutide?
Unknown. Insurers decide coverage after a drug is approved and priced. Many employer plans are already cutting coverage of weight-loss drugs for 2027, so self-pay prices may matter more than ever when retatrutide arrives.
What is the retatrutide price in the UK, India or South Africa?
There is no legal price in any country. No regulator anywhere has approved retatrutide, including the UK MHRA, India's CDSCO and South Africa's SAHPRA. Products sold under that name abroad are also unapproved.
Can I get retatrutide for free?
The only legal way to take retatrutide today is in a clinical trial. Trial drugs are given at no cost to participants. Our retatrutide clinical trials guide explains how to search for open studies.